Nanoparticles for cardiovascular diseases: identifying and overcoming barriers in translating preclinical success to clinical applications

Advanced Drug Delivery Reviews · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles